Botulinum Toxin Type A as a Therapeutic Agent in Epilepsy: Attenuation of Neuronal Ferroptosis and Cognitive Dysfunction
Brain and Behavior · 2025
DOI: 10.1002/brb3.70930 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2025. Verfasst von Shuang Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Ferroptosis, Epilepsy, Cognitive Dysfunction, Botulinum Toxins, Type A. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Purpose
Epilepsy is one of the most common neurological disorders with no effective drugs to prevent seizures or their progression. Iron modulation is a potential advanced treatment for seizures. We aim to investigate whether botulinum toxin type A (BoNT/A) can attenuate epilepsy‐induced neuronal death and maintain cognitive function by inhibiting ferroptosis.
Method
We established an epileptic rat model and intervened with BoNT/A to assess its influence on cognitive functions and the pathological damage of hippocampal tissues. Rat hippocampal neuronal cells were treated with magnesium‐free induction solution to establish an epileptic cell model and intervened using BoNT/A. Changes in ferrous ions (Fe 2+ ), malondialdehyde (MDA), and glutathione (GSH) were detected in hippocampal tissues and cells. Western blot (WB) and RT‐qPCR were used to detect the protein expression of the iron death markers, including GPX4, ACSL4, and SLC7A11. Finding We found that BoNT/A attenuated epileptiform behavior and cognitive deficits and ameliorated hippocampal tissue damage in rats under lithium chloride‐pilocarpine‐induced epilepsy. In vitro BoNT/A treatment exerted potent neuroprotective effects on hippocampal neuronal cells treated by magnesium‐free induction solution. These protective effects were related to the regulation of ferroptosis mediated by the GPX4/ACSL4/SLC7A11 proteins.
Conclusion
These results suggest that BoNT/A is effective in preventing epileptic neuronal iron death and attenuates cognitive dysfunction through the ferroptosis pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.
- Department of Stroke ICU, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, S., Huang, Z., Ma, Y., Zheng, Y., Du, M., & Lian, Y. (2025). Botulinum Toxin Type A as a Therapeutic Agent in Epilepsy: Attenuation of Neuronal Ferroptosis and Cognitive Dysfunction. Brain and Behavior. https://doi.org/10.1002/brb3.70930
Vancouver
Li S, Huang Z, Ma Y, Zheng Y, Du M, Lian Y. Botulinum Toxin Type A as a Therapeutic Agent in Epilepsy: Attenuation of Neuronal Ferroptosis and Cognitive Dysfunction. Brain and Behavior. 2025. doi:10.1002/brb3.70930
BibTeX
@article{Li2025,
author = {Li, Shuang and Huang, Zhi and Ma, Yunqing and Zheng, Yake and Du, Maiqi and Lian, Yajun},
title = {Botulinum Toxin Type A as a Therapeutic Agent in Epilepsy: Attenuation of Neuronal Ferroptosis and Cognitive Dysfunction},
journal = {Brain and Behavior},
year = {2025},
doi = {10.1002/brb3.70930}
}
EUVIMED